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RESUMEN
Se presentan dos métodos rápidos y eficientes para la 
preparación de derivados fundidos de tiazoloquinazolina 
por reacción de chalconas con hidroxilamina, urea e hidra-
to de hidrazina en condiciones de ausencia de disolventes 
y exposición a microondas. El objetivo del presente  tra-
bajo es sustituir sustancias químicas tóxicas, peligrosas, y 
altamente reactivas con bloques de síntesis menos reacti-
vos, menos nocivos pero más selectivos que pueden acti-
var reacciones químicas selectivas mediante una catálisis 
apropiada, así como sustituir tecnologías anticuadas por 
otras nuevas caracterizadas por la reducción de subpro-
ductos y una separación  fácil de los productos.
Palabras clave: LiBr, condiciones de ausencia de disol-
ventes,  Chalconas, Isoxazoles, Pirazoles, Pirimidinas.
ABSTRACT
Two rapid and efficient methods for the preparation of 
fused thiazoloquinazoline derivatives by the reaction of 
chalcones with hydroxylamine, urea and hydrazine hydrate 
under solvent free condition and microwave exposure are 
reported. The aim of present work is to substitute toxic, 
dangerous, highly reactive chemicals with less reactive, 
less harmful but more selective building blocks which 
activate selective chemical reactions by proper catalysis 
and to replace substituted old technologies to new one 
characterized by the reduction of by-products and  easy 
separation of products.
Keywords: LiBr, Solvent free condition, Chalcones, Isoxa-
zoles, Pyrazoles, Pyrimidines.
RESUM
Es presenten dos mètodes ràpids i eficients per a la pre-
paració de derivats fosos de tiazoloquinazolina per reacció 
de calcones amb hidroxilamina, urea i hidrat d’hidrazina en 
condicions d’absència de dissolvents i exposició a micro-
ones. L’objectiu del present  treball és substituir substànci-
es químiques tòxiques, perilloses i altament reactives amb 
blocs de síntesi menys reactius, menys nocius però més 
selectius que poden activar reaccions químiques selecti-
ves mitjançant una catàlisi apropiada, i també substituir 
tecnologies antiquades per altres de noves caracteritza-
des per la reducció de subproductes i una separació  fàcil 
dels productes.
Paraules clau: LiBr, condicions d’absència de dissol-
vents,  Calcones, Isoxazols, Pirazols, Pirimidines.
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INTRODUCTION 
“Preventing pollution and minimizing waste generation will 
gradually clean up sins of the past.” In this environmental 
conscious era, the role of chemistry and chemists1 involved 
is to incorporate processes and design products, which 
can eliminate or minimize the generation of associated 
pollutants. The increasing environmental consciousness of 
the chemical community has lead to search for alternative 
non-polluting media and processes that might reduce pol-
lution at the source for chemical and organic synthesis2. 
Green chemistry3 is defined as an environmentally benign 
chemical synthesis, which is the science based and eco-
nomically driven approach to achieve the goal of environ-
ment protection. In recent years, a new technique that is 
set to revolutionalize organic synthesis has moved to the 
forefront of Green chemical research. Microwave Assisted 
Organic Synthesis (MAOS) is sometimes termed as mi-
crowave induced organic reaction enhancement (MORE) 
chemistry4. It can also be termed as “e-chemistry” be-
cause it is easy, effective, economical and eco-friendly and 
is believed to be a step towards green chemistry. MORE 
chemistry techniques are potentially valuable as they re-
duce the need of organic solvents. As a result, one can 
reduce the total time for compound production as well as 
reduce the total cost per compound5. 
The Knoevenagel  condensation has been a subject of 
considerable interest and to effect this condensation ef-
ficiently, large number of catalysts have been explored6,7, 
e.g. sodium acetate in glacial acetic acid, piperidinium 
benzoate in refluxing toluene, zeolite, tetrabutyl ammo-
nium bromide, refluxing reactants in toluene at 110 ºC 
for 3 days, etc. Certainly these processes are not facile 
as they require long reaction times, high temperature and 
products are also obtained in low yields. LiBr can poten-
tially replace solvents and conventional corrosive acids in 
many of their applications 8-11. LiBr catalyses efficiently the 
three component condensation reaction of an aldehyde, 
b-ketoester and urea in refluxing acetonitrile to afford the 
corresponding dihydropyrimidinones in high yields. It is 
an improved procedure for the Biginelli reaction12. As our 
interest is to synthesize heterocyclic templates (quinazo-
linones) capable of bearing some potential pharmacoph-
ores which can enhance the inherent biological activity. 
The systematic propagation of heterocyclic rings in quin-
azolinones precursors with the installation of biological 
active heterocyclic units such as isoxazoles, pyrimidines 
and pyrazoles. Pyrimidines are found to be endowed with 
potential biological activity such as antitumor13, antiviral14, 
anticancer15, antibacterial
16 and antimicrobial17 and many 
others. Isoxazoles are reported to have bactericidal18, 
fungicidal19 and antimicrobial20 activity. Pyrazoles display 
a number of antimicrobial activities like anticancer21, an-
tidiabetic22 and antidepressants23. The quinazoline moiety 
is a useful functionality for the development of biologically 
interesting molecules with a wide portfolio of biological 
activities24 such as hypotensive25, antimalarial and anti-
hypertensive26 activities. Thus the coupling of this MORE 
synthesis with solvent free conditions and LiBr is expected 
to afford an environmentally benign synthesis of biological 
active compounds. 
RESULTS AND DISCUSSION
4-(4-Substituted phenyl)-2-thioxo-1,2,3,4,7,8-hexahydro 
quinazolin-5(6H)-ones 1(a-c) were synthesized by LiBr 
catalyzed cycloaddition of 1,3-cyclohexanedione, substi-
tuted benzaldehydes and thiourea under solvent free con-
dition and microwave exposure. The structure of 1(a) was 
confirmed by the IR bands at 3335 cm-1 due to second-
ary amino group, 1700 cm-1 due to C=O group and 1515 
cm-1 due to C=S stretching. It is supported by the pres-
ence of a broad singlet of  2 NH protons in the region of 
9.89 – 9.72 ppm in 1H NMR. The compound 1(a-c) was 
treated with chloroacetic acid in the presence of LiBr to 
give 5-(4-substituted phenyl)-8,9-dihydro-2H-thiazolo[2,3-
b] quinazolin-3,6[5H,7H]-diones  2(a-c).  Compound 2(a) 
was confirmed by the disappearance of NH stretch in 
the region of 3330 cm-1 in IR spectrum and appearance 
of an additional band at 1680 cm-1 due to C=O stretch 
of thiazolidinone moiety 1H NMR spectrum of 2(a) shows 
the appearance of a singlet of two protons at 3.67 ppm 
due to CH2 proton of thiazolidinone nucleus. Compounds 
2(a-c) were easily condensed with 4-chlorobenzaldehyde 
in the presence of LiBr to furnish 2-(4-chlorobenzylidine)-
5-(4-substituted phenyl)-8,9-dihydro-2H-thiazolo[2,3-b]
quinazolin-3,6[5H,7H]-dione 3(a-c), due to the activity of 
methylene group of compound 2(a-c).       
Synthesis of 2-arylmethylene derivatives 3(a-c) were 
achieved in a single step by treating 1(a-c) with chloro-
acetic acid and 4-chlorobenzaldehyde in the presence of 
catalytic amount of LiBr. The IR spectrum of compound 
3(a) shows the presence of α, b-unsaturated moiety by 
the appearance of carbonyl stretch at 1665 cm-1 due to 
conjugation rather than at 1680 cm-1 (C=O of thiazolidi-
none ring). Other prominent peak of C-Cl also appeared 
at 751 cm-1. 1H NMR spectrum of compound was char-
acterized by the lack of the singlet of two protons of 
thiazolidinone nucleus at 3.67 ppm and appearance of a 
new singlet at 6.42 ppm due to arylidine proton (=CH-Ar) 
of chalcone moiety. Thiazoloquinazolines are convenient 
starting material for the synthesis of fused thiazoloquin-
azolines due to their α, b-unsaturated moiety.  Firstly, the 
absence of carbonyl stretching frequency in the region of 
1665 cm-1 confirms the formation of products. Isoxazo-
lino derivatives 4(a-c) were synthesized by the reaction of 
compound 3(a-c) with equimolar ratio of hydroxylamine 
hydrochloride in the presence of LiBr. The structure of 4(a) 
was confirmed by appearance of absorption band at 1093 
m-1 due to C-O stretch and at 940 cm-1 due to N-O stretch 
in IR spectrum. It is supported by the presence of two 
doublets of two methine protons of isoxazolino moiety at 
about 4.83 and 3.12 ppm in 1H NMR. Compounds 3(a-c) 
treated with hydrazine hydrate in the presence of LiBr as a 
catalyst yielded 3-(4-chlorobenzylidine)-10-(4-substituted 
phenyl)-6,7,8-trihydro-3H,3aH,2H-pyrazolo [3’4’:4,5]thia-
zolo [2,3-b]quinazoline-9[10H]-ones 5(a-c). Its structure 
was confirmed by the disappearance of carbonyl stretch-
ing frequency in the region of 1665 cm-1 in IR spectrum. 
The methane protons of pyrazoline ring appeared as two 
doublets centered at 4.98 and 3.43 ppm in its 1H NMR 
spectrum. Pyrimidino derivatives of compounds 6(a-c) 
were synthesized by the reaction of compounds 3(a-c) 
with equimolar ratio of urea in the presence of LiBr as a 
catalyst. The IR spectrum showed a new absorption band 
in the region of 1687 cm-1 was assigned to new carbonyl 
group (=N-C=O) and in the region of 3327 cm-1 due to NH 
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stretch. A broad signal at 8.84 ppm was observed for the 
NH proton in the 1H NMR spectrum and it confirms the 
formation of the product 6(a). 
Antimicrobial activity
Four compounds were screened in vitro for their antimicro-
bial activities against four strains of bacteria (Escherichia 
coli, Bacillus subtilis, Klebsiella pneumoniae, Pseudomo-
nas aeuroginosa) and two strains of fungi (Aspergillus fu-
migatus, Candida albicans) using the disc diffusion meth-
od. Commercial antibacterial ciprofloxacin and antifungal 
fluconazole were also screened under similar conditions 
for comparison. The results have been tabulated in the 
form of inhibition zones and activity index in Table 4.
The results revealed that all tested compounds exhibit 
moderate to strong activity against both fungi and E. coli. 
Compounds 4(a), 5(a) and 6(a) show considerable potency 
against A. fumigatus while against C. albicans,  they are 
moderately active. Similarly, compound 6(a) was found to 
show strong activity against K. pneumonae and P. aeuro-
genosa. 5(a) was found to show excellent activity against 
K. pneumonae while against P. aeurogenosa, it exhibited 
moderate activity.
Table 1 : Physical data of synthesized compounds
a = Conventional, b = Microwave + Solvent, c = Microwave + LiBr (solvent free) under microwave irradiation
Compd. Ar Ar’ Mol. Formula Mol. Weight M.P. (ºC) Yield 
a %
[Time] (hr.)
Yield b %
[Time] (min.)
Yield c% 
[Time] (min.)
1a 4-FC6H4            - C14H13N2OSF 276     275
66
[16]
69
[6]
76
[4]
1b 4-OCH3C6H4            - C15H16N2O2S 288     270
65
[6]
86
[5]
80
[3]
1c -C6H5            - C14H14N2OS 258     264
68
[6]
72
[4.5]
89
[2.5] 
2a 4-FC6H4            - C16H13N2O2SF 316     224
73
[6]
75
[4.5]
87
[3]
2b 4-OCH3C6H4            - C17H16N2O3S 328     220
70
[6]
76
[4.5]
87
[3]
2c -C6H5            - C16H14N2OS 298     214
68
[8]
72
[6]
86
[5]
3a 4-FC6H4 4-ClC6H4 C23H16N3O2SFCl 438     230
69
[8]
72
[5.5]
88
[4]
3b 4-OCH3C6H4 4-ClC6H4 C24H19N3O3ClS 450     231
68
[6]
70
[6]
80
[5]
3c -C6H5 4-ClC6H4 C23H17N2O2ClS 420     228
68
[8]
70
[6]
86
[5]
4a 4-FC6H4 4-ClC6H4 C23H16N3O2SFCl 452     251
79
[3]
82
[6]
90
[5]
4b 4-OCH3C6H4 4-ClC6H4 C24H19N3O3ClS 464
    239 65
[3]
80
[6]
87
[5]
4c -C6H5 4-ClC6H4 C23H17N3O2ClS 434
    242 61
[3]
68
[7]
75
[4.5]
5a 4-FC6H4 4-ClC6H4 C25H19N4O2SFCl 493
    265 65
[14]
70
[7]
87
[6] 
5b 4-OCH3C6H4 4-ClC6H4 C26H22N4O3ClS 505
    247 65
[14]
77
[6]
85
[6]
5c -C6H5 4-ClC6H4 C25H20N4O2ClS 475
    251 70
[14]
76
[6]
81
[6.5]
6a 4-FC6H4 4-ClC6H4 C24H16N4O2SFCl 478
    215 68
[12]
75
[8]
92
[7]
6b 4-OCH3C6H4 4-ClC6H4 C25H19N4O3ClS 490
    213 64
[12]
70
[8]
87
[7]
6c -C6H5 4-ClC6H4 C24H17N4O2ClS 460
    221 66
[12]
74
[9]
89
[7.5]
Table 2 : Analytical data of synthesized compounds
Compd. Calculated / Found (%)
C H N S
1a 60.86 / 60.84 4.71 / 4.69 10.14 / 10.00 11.59 / 11.57
1b 62.50 / 62.48 5.55 / 5.58 9.72 / 9.68 11.11 / 10.99
1c 65.11 / 65.13 5.42 / 5.38 10.85 / 10.79 12.40 / 12.38
2a 60.75 / 60.79 2.82 / 2.83 19.61 / 19.60 10.12 / 9.90
2b 62.19 / 62.01 3.91 / 3.88 8.43 / 8.40 9.75 / 9.68
2c 64.42 / 64.36 4.69 / 4.65 8.53 / 8.58 10.73 / 10.68
3a 63.01 / 62.97 3.65 / 3.61 6.39 / 6.27 7.30 / 7.27
3b 64.00 / 64.06 4.22 / 4.16 6.22 / 6.15 7.11 / 7.07
3c 65.71 / 65.67 4.04 / 3.97 6.66 / 6.61 7.61 / 7.59
4a 61.06 / 60.98 3.53 / 3.49 9.29 / 9.27 7.07 / 7.10
4b 62.06 / 62.01 4.09 / 4.11 9.05 / 8.98 6.89 / 6.81
4c 63.59 / 63.51 3.91 / 3.94 9.67 / 9.54 7.37 / 7.28
5a 60.85 / 60.78 3.85 / 3.87 11.35 / 11.31 6.49 / 6.43
5b 61.78 / 61.72 4.35 / 4.29 11.08 / 10.98 6.33 / 6.28
5c 63.15 / 63.05 4.21 / 4.17 11.78 / 11.72 6.73 / 6.69
6a 60.25 / 60.17 3.34 / 3.36 11.71 / 11.69 6.69 / 6.63
6b 61.22 / 61.18 3.87 / 3.78 11.42 / 11.29 6.53 / 6.56
6c 62.60 / 62.55 3.69 / 3.61 12.17 / 12.09 6.95 / 6.90
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Table 3: Spectral data of synthesized compounds
Compd. Spectral Data
1a IR (KBr cm-1):
1H NMR d:
3067 (C-H str., Ar-H), 3335 (NH str.), 2921, 2842 (CH str., CH2), 1700 (C=O str.), 1605, 1525 (C=C str.), 
1515, 1231 (C=S amide II and amide I), 1182 (C-F str.) and 835 (Ar-H bend, 1,4-disubs.) 
9.89 – 9.72 (s, 2H, NH), 2.86 – 1.62 (m, 6H, -CH2), 5.02 (s, 1H, CH-Ar) and 7.97 - 7.15 (m, 4H, Ar-H). 
1b IR (KBr cm-1): 
1H NMR  d:
3062 (C-H str., Ar-H), 3328 (NH str.), 2933, 2851 (CH str., CH2), 1710 (C=O str.), 1612, 1519 (C=C str.), 
1516, 1225 (C=S amide II and amide I), 1093 (C-O str.) and 843 (Ar-H bend, 1,4-disubs.) 
9.95 – 9.62 (bs, 2H, NH), 2.90 – 1.63 (m, 6H, -CH2), 5.09 (s, 1H, CH-Ar) and 7.93 - 7.05 (m, 4H, Ar-H).
1c IR (KBr cm-1): 
1H NMR d:
3055 (C-H str., Ar-H), 3337 (NH str.), 2926, 2852 (CH str., CH2), 1709 (C=O str.), 
1607, 1527 (C=C str.) and 1524, 1222 (C=S amide II and amide I str.),  
9.83 – 9.57 (bs, 2H, NH), 2.90 – 1.63 (m, 6H, -CH2), 5.08 (s, 1H, CH-Ar) and 7.96 - 7.03 (m, 5H, Ar-H). 
2a IR (KBr cm-1): 
1H NMR d:
3057 (C-H str., Ar-H), 2932, 2835 (CH str., CH2), 1695 (C=O str.), 1680 (C=O, thiazolidinone ring), 1610 (C=N str.), 
1600, 1530 (C=C str.), 1195 (C-F str.), 1115 (C-N str.), 841(Ar-H bend, 1,4-disubs.) and 695 (C-S-C str.).
7.86 - 7.17 (m, 4H, Ar-H), 5.96 (s, 1H, CH-Ar), 3.67 (s, 2H, -CH2, thiazolidinone ring) and 2.90 – 1.66 (m, 6H, -CH2). 
2b IR (KBr cm-1): 
1H NMR d:
3047 (C-H str., Ar-H), 2918, 2845 (CH str., CH2), 1697 (C=O str.), 1678 (C=O, thiazolidinone ring), 1611 (C=N str.), 
1618, 1539 (C=C str.), 1082 (C-O str.), 1108 (C-N str.), 835 (Ar-H bend, 1,4-disubs.) and 689 (C-S-C str.).
7.91- 7.07 (m, 4H, Ar-H), 5.93 (s, 1H, CH-Ar), 3. 55 (s, 2H, -CH2, thiazolidino-
ne ring), 3.84 (s, 3H, -OCH3) and 2. 83 – 1.59 (m, 6H, -CH2). 
2c IR (KBr cm-1): 
1H NMR d:
3049 (C-H str., Ar-H), 2925, 2842 (CH str., CH2), 1699 (C=O str.), 1682 (C=O, thiazolidino-
ne ring), 1608 (C=N str.), 1612, 1541 (C=C str.), 1101 (C-N str.) and 699 (C-S-C str.).
7.73- 7.02 (m, 5H, Ar-H), 5.90 (s, 1H, CH-Ar), 3. 61 (s, 2H, -CH2, thiazolidinone ring) and 2. 87 – 1.58 (m, 6H, -CH2). 
3a IR (KBr cm-1): 
1H NMR d:
3075 (C-H str., Ar-H), 2954, 2851 (CH str., CH2), 1694 (C=O str.), 1665 (C=C-C=O, chalcone carbonyl str.), 1620 (C=N str.), 
1607, 1513 (C=C str.), 1175 (C-F str.), 751 (C-Cl str.), 1116 (C-N str.), 843 (Ar-H bend, 1,4-disubs.) and 681 (C-S-C str.).
7.73 - 7.01 (m, 8H, Ar-H), 6.32 (s, 1H, =CH-Ar’), 5.59 (s, 1H, CH-Ar) and 2.89 – 1.53 (m, 6H, -CH2). 
3b IR (KBr cm-1): 
1H NMR d:
3056 (C-H str., Ar-H), 2929, 2850 (CH str., CH2), 1690 (C=O str.), 1662 (C=C-C=O, chalco-
ne carbonyl str.), 1617 (C=N str.), 1616, 1503 (C=C str.), 1182 (C-O str.), 749 (C-Cl str.),  1115 
(C-N str.), 749 (C-Cl str.),  842 (Ar-H bend, 1,4-disubs.) and 674 (C-S-C str.).
7.79 - 7.07 (m, 8H, Ar-H), 6.40 (s, 1H, =CH-Ar’), 5.54 (s, 1H, CH-Ar), 3.74 (s, 3H, -OCH3) and 2.81– 1.56 (m, 6H, -CH2). 
3c IR (KBr cm-1): 
1H NMR d:
3064 (C-H str., Ar-H), 2923, 2849 (CH str., CH2), 1701 (C=O str.), 1664 (C=C-C=O, chalcone carbonyl str.), 1628 (C=N str.), 
1627, 1507 (C=C str.), 749 (C-Cl str.),  1114 (C-N str.), 747 (C-Cl str.),  839 (Ar-H Bend, 1,4-disubs.) and 684 (C-S-C str.).
7.83 - 7.02 (m, 9H, Ar-H), 6. 34 (s, 1H, =CH-Ar’), 5.63 (s, 1H, CH-Ar) and 2.85– 1. 63 (m, 6H, -CH2). 
4a IR (KBr cm-1): 
1H NMR d:
3095 (C-H str., Ar-H), 2922, 2836 (CH str., CH2), 1703 (C=O str.), 1625 (C=N str.), 1609, 1505 (C=C str.), 1162 (C-F str.), 
1093 (C-O str.), 940 (N-O str.), 816 (Ar-H bend, 1,4-disubs.), 745 (C-Cl str.), 1116 (C-N str.) and 683 (C-S-C str.).
7.96 - 7.13 (m, 8H, Ar-H), 5.30 (s, 1H, CH-Ar), 4.83 (d, 1H, -CH-Ar’ isoxazoli-
ne ring), 3.12 (d, 1H, -CH-S) and 2.90 – 1.73 (m, 6H, -CH2).
4b IR (KBr cm-1): 
1H NMR d:
3080 (C-H str., Ar-H), 2918, 2849 (CH str., CH2), 1699 (C=O str.), 1628 (C=N str.), 1617, 1510 (C=C str.), 1080 
(C-O str.), 930 (N-O str.), 820 (Ar-H bend, 1,4-disubs.), 755 (C-Cl str.), 1115 (C-N str.),  and 676 (C-S-C str.).
7.61 - 7.03 (m, 8H, Ar-H), 5.28 (s, 1H, CH-Ar), 4.81 (d, 1H, -CH-Ar’ isoxazoline ring), 
3.82 (s, 3H –OCH3), 3.08 (d, 1H, -CH-S) and 2.78 – 1.53 (m, 6H, -CH2). 
4c IR (KBr cm-1): 
1H NMR d:
3076 (C-H str., Ar-H), 2925, 2851 (-CH str., CH2), 1700 (C=O str.), 1630 (C=N str.), 1619, 1500 (C=C str.), 
1091 (C-O str.), 943 (N-O str.), 810 (Ar-H bend, 1,4-disubs.), 749 (C-Cl str.) and 671 (C-S-C str.).
7.81 - 7.11 (m, 9H, Ar-H), 5.27 (s, 1H, CH-Ar), 4.80 (d, 1H, -CH-Ar’ isoxazoli-
ne ring), 3.08 (d, 1H, -CH-S) and 2.87 – 1.61 (m, 6H, -CH2). 
5a IR (KBr cm-1): 
1H NMR d:
3083 (C-H str., Ar-H), 2965, 2843 (CH str., CH2), 1700 (C=O str.), 1627 (C=N str.), 1610, 1495 (C=C str.), 
1172 (C-F str.), 824 (Ar-H bend, 1,4-disubs.), 732 (C-Cl str.), 1115 (C-N str.), and 682 (C-S-C str.).
7.73 - 7.01 (m, 8H, Ar-H), 5.32 (s, 1H, CH-Ar), 4.98 (d, 1H, -CH-Ar’ pyrazoli-
ne ring), 3.43 (d, 1H, -CH-S) and 2.93 – 1.62 (m, 6H, -CH2). 
5b IR (KBr cm-1): 
1H NMR d:
3080 (C-H str., Ar-H), 2954, 2847 (CH str., CH2), 1705 (C=O str.), 1620 (C=N str.), 1611, 1505 (C=C str.), 
1083 (C-O str.), 837 (Ar-H bend, 1,4-disubs.), 741 (C-Cl str.), 1114 (C-N str.), and 674 (C-S-C str.).
7.73 – 7.01 (m, 8H, Ar-H), 5.29 (s, 1H, CH-Ar), 5.01 (d, 1H, -CH-Ar’ pyrazoline ring), 
3.80 (s, 3H, -OCH3), 3.37 (d, 1H, -CH-S) and 2.87 – 1.59 (m, 6H, -CH2).
5c IR (KBr cm-1): 
1H NMR d:
3074 (C-H str., Ar-H), 2959, 2852 (CH str., CH2), 1703 (C=O str.), 1628 (C=N str.), 1602, 1515 (C=C 
str.), 830 (Ar-H bend, 1,4-disubs.), 730 (C-Cl str.), 1115 (C-N str.) and 678 (C-S-C str.).
 7.69 – 7.01 (m, 9H, Ar-H), 5.26 (s, 1H, CH-Ar), 4.93 (d, 1H, -CH-Ar’ pyrazoli-
ne ring), 3.31 (d, 1H, -CH-S) and 2.89– 1.63 (m, 6H, -CH2).
6a IR (KBr cm-1): 
1H NMR d:
3327 (NH str.), 3015 (CH str., Ar-H), 2911, 2831 (CH str. CH2), 1710, 1687 (C=O str.), 1620 (C=N str.), 1607, 
1527 (C=C str.), 1182 (C-F str.), 730 (C-Cl str.), 841 (Ar-H bend, 1, 4-disubs.) and 678 (C-S-C str.)
8.94 (s, 1H, NH), 7.68-7.09 (m, 8H, Ar-H), 5.23 (s, 1H, CH-Ar) and 2.86-1.61 (m, 6H, -CH2) 
6b IR (KBr cm-1): 
1H NMR d:
3324(NH str.), 3025 (CH str., Ar-H), 2921, 2842 (CH str., CH2), 1705, 1681 (C=O str.), 1630 (C=N str.), 1603, 
1499 (C=C str.), 741 (C-Cl str.), 1079 (C-O str.), 837 (Ar-H bend, 1, 4-disubs.) and 669 (C-S-C str.)
8.80 (s, 1H, NH), 7.61-7.07 (m, 8H, Ar-H), 5.25 (s, 1H, CH-Ar), 3.78 (s, 3H –OCH3) and 2.81-1.53 (m, 6H, -CH2) 
6c IR (KBr cm-1): 
1H NMR d:
3327(NH str.), 3028 (CH str., Ar-H), 2925, 2837 (CH str., CH2), 1710, 1685 (C=O str.), 1628 (C=N str.), 
1614, 1502 (C=C str.), 745 (C-Cl str.), 832 (Ar-H bend, 1, 4-disubs.) and 673 (C-S-C str.).
8.92 (s, 1H, NH), 7.51-7.01 (m, 8H, Ar-H), 5.19 (s, 1H, CH-Ar) and 2.82-1.61 (m, 6H, -CH2).
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EXPERIMENTAL SECTION
General Procedure
All reactions were carried out in a domestic microwave 
oven (Kenstar, Model No. OM-26 EGO). Melting points are 
uncorrected and determined in open capillaries. Reactions 
were monitored by thin layer chromatography using silica 
gel-G as adsorbent using ethyl acetate : n-hexane (7 : 3) 
as eluent and products were detected by iodine vapors. 
IR spectra (KBr pellets) were recorded on Perkin-Elmer 
1800 (FTIR) spectrometer. 1H NMR spectra (DMSO-d6) 
were taken on a Bruker DRX spectrometer (300 MHz FT 
NMR) using TMS as internal standard and chemical shift 
were expressed in d. Mass spectra were taken on a JEOL 
SX-102/PA-6000 (EI) spectrometer and elemental analysis 
was carried out on  C, H, N analyzer (Elemental Vario Carlo 
Alba 1108). The results were found to be in good agree-
ment with the calculated values (± 0.2%). The starting 
compounds were prepared according to reported method.
Microwave induced synthesis of 4-(4-substituted 
phenyl)-2-thioxo-1,2,3,4,7,8-hexahydro quinazolin-
5(6H)-ones  1(a - c):  
A mixture of thiourea (0.01 mole), aromatic aldehydes (0.01 
mole), 1,3-cyclohexadione (0.01 mole) and LiBr (10 mole 
%) was mixed with a glass rod and placed in small conical 
flask at room temperature. The mixture was then exposed 
to microwave radiations at 80 % power for 2-3 minutes. 
After completion of reaction (monitored by TLC), the re-
action mixture was cooled to room temperature. 15 mL 
of water was then added to reaction mixture and it was 
stirred for 5 minutes. The solid thus obtained was filtered, 
dried and recrystallized from ethanol. 
Conventional synthesis of 4-(4-substituted phenyl)-
2-thioxo-1,2,3,4,7,8-hexahydro quinazolin-5(6H)-ones 
1(a-c):  
A mixture of thiourea (0.01 mole), aromatic aldehydes (0.01 
mole), 1,3-cyclohexadione (0.01 mole), absolute alcohol 
(25 mL) and 36% HCl (1 mL) was refluxed for about 5 hr on 
a water bath. The solvent was removed and residue was 
recrystallized from ethanol to yield compound 1(a – c). 
Microwave induced synthesis of 5-(4-substituted phe-
nyl)-8, 9-dihydro-2H-thiazolo [2, 3-b] quinazolin-3, 
6[5H,7H]-diones 2(a-c):  
Compound 1(a-c) (0.01 mole), chloroacetic acid (0.01 
mole) and LiBr (10 mole %) was placed in small conical 
flask and mixed with a glass rod at room temperature. 
The mixture was then exposed to microwave radiations 
at 60 % power for 3-4 minutes. After completion of reac-
tion (monitored by TLC), the reaction mixture was cooled 
to room temperature. 15 mL of water was then added to 
reaction mixture and it was stirred for 5 minutes. The solid 
thus obtained was filtered, dried and recrystallized from 
ethanol. 
Conventional synthesis of 5-(4-substituted phenyl)-8,9-
dihydro-2H-thiazolo[2,3-b]quinazolin-3,6[5H,7H]-dio-
nes 2(a-c): 
Compound 1(a-c) (0.01 mole), chloroacetic acid (0.01 
mole) and fused CH
3COONa (0.5 g) in acetic acid (10 mL) 
was refluxed for about 7 hr on a heating mantle. After cool-
ing, the reaction mixture was poured into ice cold water. 
The solid separated was filtered off and recrystallized from 
ethanol to obtain compounds 2(a-c).
Microwave induced synthesis of 2-(4-chlorobenzylidine)-
5-(4-substituted phenyl)-8,9-dihydro-2H-thiazolo[2,3-
b]quinazolin-3,6[5H,7H]-diones 3(a-c):  
Method – 1
Compound 2(a-c) (0.01 mole), 4-chlorobenzaldehyde (0.01 
mole) and LiBr (10 mole %) were mixed with mortar-pestle 
and placed in small conical flask at room temperature. 
The mixture was then exposed to microwave radiations at 
50% power for 3-3.30 minutes. After completion of reac-
tion (monitored by TLC), the reaction mixture was cooled 
to room temperature. 15 mL of water was then added to 
reaction mixture and it was stirred for 5 minutes. The solid 
thus obtained was filtered, dried and recrystallized from 
ethanol.
Method – 2
Compound 1(a-c) (0.01mole), chloroacetic acid (0.01 
mole), 4-chlorobenzaldehyde (0.01 mole) and LiBr (10 
mole %) were placed in small conical flask and mixed with 
a glass rod at room temperature. The mixture was then 
exposed to microwave radiations at 50% power for 6-6.30 
minutes. After completion of reaction (monitored by TLC), 
the reaction mixture was cooled to room temperature. 15 
mL of water was then added to reaction mixture, stirred for 
Table 4 : Antimicrobial activity of some synthesized compounds (500 ppm)
Compd. Antifungal activity (Activity index) Antibacterial activity
(Activity index)
A. fumigatus C. albicans E.coli B.subtilis P.aeuroginosa K.pneumoniae
4a 20 19
(0.63)
17
(0.50)
15
(0.43)
24
(0.54)
13
(0.34)
5a 24 20
(0.66)
12
(0.35)
11
(0.31)
14
(0.32)
34
(0.89)
6a 22 23
(0.76)
17
(0.50)
16
(0.46)
27
(0.61)
28
(0.73)
C1 Nil 30 - - - -
C2 - - 34 35 44 38
a Activity index = Inhibition area of the sample / inhibition area of the standard.
Standard: C1 = Fluconazole, C2 = Ciprofloxacin.
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5 minutes. The solid thus obtained was filtered, dried and 
recrystallized from ethanol to afford compounds 3(a-c).
Conventional synthesis of 2-(4-Chlorobenzylidine)-
5-(4-substituted phenyl)-8,9-dihydro-2H-thiazolo[2,3-
b]quinazolin-3,6[5H,7H]-diones  3(a-c):  
Compound 2(a-c) (0.01 mole), 4-chlorobenzaldehyde 
(0.01 mole) and 2-3 drops of glacial acetic acid in ethanol 
(25 mL) was refluxed on heating mantle for about 6 hr. The 
solvent was removed and residue was recrystallized from 
ethanol. 
Microwave induced synthesis of 3-(4-chlorobenzylidine)-
10-(4-substituted phenyl)-6,7,8-trihydro-3H,3aH-isoxa-
zolo [3’4’:4,5]thiazolo [2,3-b]quinazoline-9[10H]-ones  
4(a-c)
Compound 3(a-c) (0.01 mole), hydroxylamine hydrochlo-
ride (0.012 mole) and LiBr (10 mole %) were mixed with 
mortar - pestle and placed in a small conical flask at room 
temperature. The mixture was then exposed to microwave 
radiations at 60% power for 5-5.30 minutes. After comple-
tion of reaction (monitored by TLC), the reaction mixture 
was cooled to room temperature. 15 mL of water was then 
added to reaction mixture and it was stirred for 5 minutes. 
The solid thus obtained was filtered, dried and recrystal-
lized from ethanol to afford compounds 4(a-c).
Conventional synthesis of 3-(4-chlorobenzylidinel)-
10-(4-substituted phenyl)-6,7,8-
trihydro-3H,3aH-isoxazolo [3’4’:4,5]thiazolo [2,3-b]
quinazoline-9[10H]-ones 4(a-c)
To a mixture of compound 3(a-c) (0.01 mole) and hydrox-
ylmine hydrochloride (0.012 mole) in absolute ethanol, 
(0.01 mole), a solution of sodium acetate (0.012 mole) in 
acetic acid (5 mL) was added. The reaction mixture was 
refluxed on heating mantle for 12 hr. The reaction mixture 
was concentrated, kept overnight and poured into ice wa-
ter. The resulting solid was filtered, washed with water and 
recrystallized from acetic acid. 
Microwave induced synthesis of 3-(4-chlorobenzylidine)-
10-(4-fluorophenyl)-
6,7,8-trihydro-3H,3aH,2H-pyrazolo [3’4’:4,5]thiazolo 
[2,3-b]quinazoline-9[10H]-ones 5(a-c)
Compound 3(a-c) (0.01 mole), hydrazine hydrate (0.02 
mole) and LiBr (10 mole %) were placed in a small coni-
cal flask and mixed with a glass rod at room temperature. 
The mixture was then exposed to microwave radiations at 
60% power for 6-6.30 minutes. After completion of reac-
tion (monitored by TLC), the reaction mixture was cooled 
to room temperature. 15 mL of water was then added to 
reaction mixture and it was stirred for 5 minutes. The solid 
thus obtained was filtered, dried and recrystallized from 
ethanol to afford compounds 5(a-c).
Conventional synthesis of 3-(4-chlorobenzylidine)-
10-(4-substituted phenyl)-6,7,8-
trihydro-3H,3aH,2H-pyrazolo [3’4’:4,5]thiazolo [2,3-b]
quinazoline-9[10H]-ones 5(a-c)
A solution of compound 3(a-c) (0.01 mole) in abso lute eth-
anol (30 mL) was treated with hydrazine hydrate in excess 
(0.02 mole) and refluxed on heating mantle in the presence 
of glacial acetic acid as a catalyst for 14 hr. The reaction 
mixture was concentrated, kept overnight and poured into 
ice water. The resulting solid was filtered, washed with wa-
ter and recrystallized from absolute ethanol to afford com-
pounds 5(a-c). 
Microwave induced synthesis of 4-(4-chlorophenyl)-
11-(4-substituted phenyl)-7,8,9-trihydro-2H-pyrimido 
[4’5’:4,5]thiazolo [2,3-b]quinazoline-2,10 [3H,11H]-
diones 6(a-c)
Compound 3(a-c) (0.01 mole), urea (0.01 mole) and LiBr 
(10 mole %) were placed in small conical flask and mixed 
with a glass rod at room temperature. The mixture was 
then exposed to microwave radiations at 60% power for 
7-7.30 minutes. After completion of reaction (monitored by 
TLC), the reaction mixture was cooled to room tempera-
ture. 15 mL of water was then added to reaction mixture 
and it was stirred for 5 minutes. The solid thus obtained 
was filtered, dried and recrystallized from ethanol. 
Conventional synthesis of 4-(4-Chlorophenyl)-11-phe-
nyl-7,8,9-trihydro-2H-
pyrimido[4’5’:4,5]thiazolo [2,3-b]quinazoline-2,10 
[3H,11H]-diones 6(a-c)
A solution of compound 3(a-c) (0.01 mole) in absolute 
ethanol (30 mL) was treated with urea (0.01 mole). A few 
drops of conc. HCl were added and refluxed on a heating 
mantle  for 12 hr. The reaction mixture was concentrat-
ed, kept overnight, poured into ice water and neutralized 
with 5N NaOH solution. The solid product was colleced, 
washed several times with water and recrystallized from 
absolute ethanol. 
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